PROSPECÇÃO TECNOLÓGICA DO POTENCIAL TERAPÊUTICO DE MOLÉCULAS EXTRAÍDAS DE ACMELLA OLERACEA (L.) R.K. JANSEN (SPILANTHES OLERACEA)
The objective of this study is to carry out a technological search for patent documents related to the use of compounds extracted from Acmella oleracea (L.) R.K. Jansen for medicinal purposes. Technological prospecting was carried out using the Orbit Intelligence database, using the keywords “acmell...
| Autores: | , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2024 |
| País: | Brasil |
| Institución: | Universidade Federal de Roraima (UFRR) |
| Repositorio: | Revista de Administração de Roraima - RARR |
| Idioma: | portugués |
| OAI Identifier: | oai:oai.revista.ufrr.br:article/8088 |
| Acceso en línea: | https://revista.ufrr.br/adminrr/article/view/8088 |
| Access Level: | acceso abierto |
| Palabra clave: | Biomolecules Jambu Brazilian Biodiversity Biomoléculas Biodiversidade Brasileira |
| Sumario: | The objective of this study is to carry out a technological search for patent documents related to the use of compounds extracted from Acmella oleracea (L.) R.K. Jansen for medicinal purposes. Technological prospecting was carried out using the Orbit Intelligence database, using the keywords “acmella oleracea” and “spilanthes oleracea”, and the A61K patent classification, without temporal or spatial delimitation, with the aim of identifying and understanding the innovations that are driving this sector. A total of 114 patent families were found, which showed a growing investment trend until 2022, with a drop in 2023. With regard to current patents, the United States, China and Germany stand out as the main depositors, while Brazil comes in fourth place. The strong presence of the United States is reinforced with the presence of Nulixir, BodyBio and Mary Kay among the top five depositing companies. In Brazil, IES stands out as the main depositors |
|---|